Trademarkia Logo

Canada

C$
LockBody
REGISTERED

on 8 May 2025

Last Applicant/ Owned by

Ultrahuman Six Limited

C/O Kreston Reeves LLP Innovation House, Ramsgate Road,Sandwich, Kent, CT13 9FF

GB

Serial Number

1966451 filed on 3rd Jun 2019

Registration Number

TMA1311319 registered on 8th May 2025

Registration expiry Date

8th May 2035

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

LockBody

Trademark usage description

pharmaceutical products and preparations for the prevention and treatment of autoimmune, cardiovascular, central nervous system, gastrointestinal, gen Read More

Classification Information


Class [005]
Pharmaceutical products and preparations for the prevention and treatment of autoimmune, cardiovascular, central nervous system, gastrointestinal, genetic, immunological, menopausal, metabolic, musculoskeletal, neurodegenerative, ophthalmological, respiratory, urogenital, oncological, and urological diseases and disorders; pharmaceutical products and preparations for the prevention and treatment of endocrine diseases and disorders namely diabetes, growth and thyroid disorders, Hashimoto thyroiditis, cancers of the endocrine glands, Addison's disease; pharmaceutical products and preparations for the prevention and treatment of infectious diseases and disorders namely urinary tract infections, respiratory infections; anti-inflammatory preparations; pharmaceutical products and preparations for the prevention and treatment of neurological diseases and disorders namely Alzheimer's, cerebral palsy, brain injury, spinal cord injury, epilepsy, stroke, brain tumors; pharmaceutical products and preparations for the prevention and treatment of neuromuscular diseases and disorders namely multiple sclerosis, Parkinson's diseases, amyotrophic lateral sclerosis, Guillain-Barré syndrome, muscular dystrophies, peripheral neuropathies, myopathies; pharmaceutical products and preparations for the prevention and treatment of psychiatric diseases and disorders namely schizophrenia, mood disorders, anxiety disorders, cognitive disorders, bipolar disorders; pharmaceutical products and preparations for the prevention and treatment of viral diseases and disorders namely Acquired Immune Deficiency Syndrome (AIDS), herpes, viral skin infections, respiratory illnesses, sexually transmitted diseases; pharmaceutical products and preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical products and preparations, namely, antifungal preparations, antiviral preparations, antibiotics; and dermatological preparations for the treatment of acne, rosacea, dermatitis, eczema, psoriasis, skin cancer


Classification kind code

12

Mark Details


Serial Number

1966451

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 21st Oct 2024
Approved
Submitted for opposition 27
on 21st Oct 2024
Approval Notice Sent
Submitted for opposition 48
on 12th Mar 2024
Agent Changed
Submitted for opposition 15
on 29th Feb 2024
Correspondence Created
Submitted for opposition 22
on 7th Feb 2024
Search Recorded
Submitted for opposition 20
on 7th Feb 2024
Examiner's First Report
Submitted for opposition 287
on 12th Apr 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 5th Jun 2019
Formalized
Submitted for opposition 1
on 4th Jun 2019
Created
Submitted for opposition 30
on 3rd Jun 2019
Filed